Abstract
Aim: To assess patient perception toward oral chemotherapy for solid tumors, the Italian Association of Medical Oncology performed a large multi-institutional national survey. Methods: A 17-item anonymous questionnaire including 7 general and 10 investigational questions with free-text, single-choice, or multiple-choice answers was administered. Analysis of response distribution according to predefined factors was described by summary measures and conducted by χ2 test and other nonparametric tests. Results: From January to June 2010, 581 patients completed the questionnaire; data of 404 patients constituted the final study sample. Three groups could be distinguished according to treatment: IV chemotherapy (IV group, n = 313), oral chemotherapy (oral group, n = 48), or combined therapy (combined group, n = 43). Thirty-one (72%) patients in the combined group and 187 (60%) in the IV group expressed preference for oral therapy (p = 0.028). Limitations in family and work commitment were more frequently perceived by patients on IV than oral chemotherapy (147 (47%) vs 14 (29%) patients, p
| Original language | English |
|---|---|
| Pages (from-to) | 108-113 |
| Number of pages | 6 |
| Journal | Tumori |
| Volume | 102 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 1 2016 |
Fingerprint
Keywords
- IV chemotherapy
- Oral chemotherapy
- Patient perspective
- Questionnaire
- Treatment
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Oral chemotherapy and patient perspective in solid tumors : A national survey by the Italian association of medical oncology. / Aurilio, Gaetano; Gori, Stefania; Noie, Franco; Pruned, Giancarlo; Coati, Francesca; Torri, Valter; Lunardi, Gianluigi; Atzori, Francesco; La Verde, Nicla; Banna, Giuseppe Luigi; Rossi, A.; Del Mastro, Lucia; Di Fabio, Francesca; Marcon, Maria; Gebbia, V.; Loupakis, Fotios; Orlando, Laura; Ciuffreda, Libero; Amadio, Placido; Luppi, Gabriele; Redana, Stefania; Filippelli, G.; Gentile, Anna Lisa; Collovà, Elena.
In: Tumori, Vol. 102, No. 1, 01.01.2016, p. 108-113.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Oral chemotherapy and patient perspective in solid tumors
T2 - A national survey by the Italian association of medical oncology
AU - Aurilio, Gaetano
AU - Gori, Stefania
AU - Noie, Franco
AU - Pruned, Giancarlo
AU - Coati, Francesca
AU - Torri, Valter
AU - Lunardi, Gianluigi
AU - Atzori, Francesco
AU - La Verde, Nicla
AU - Banna, Giuseppe Luigi
AU - Rossi, A.
AU - Del Mastro, Lucia
AU - Di Fabio, Francesca
AU - Marcon, Maria
AU - Gebbia, V.
AU - Loupakis, Fotios
AU - Orlando, Laura
AU - Ciuffreda, Libero
AU - Amadio, Placido
AU - Luppi, Gabriele
AU - Redana, Stefania
AU - Filippelli, G.
AU - Gentile, Anna Lisa
AU - Collovà, Elena
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Aim: To assess patient perception toward oral chemotherapy for solid tumors, the Italian Association of Medical Oncology performed a large multi-institutional national survey. Methods: A 17-item anonymous questionnaire including 7 general and 10 investigational questions with free-text, single-choice, or multiple-choice answers was administered. Analysis of response distribution according to predefined factors was described by summary measures and conducted by χ2 test and other nonparametric tests. Results: From January to June 2010, 581 patients completed the questionnaire; data of 404 patients constituted the final study sample. Three groups could be distinguished according to treatment: IV chemotherapy (IV group, n = 313), oral chemotherapy (oral group, n = 48), or combined therapy (combined group, n = 43). Thirty-one (72%) patients in the combined group and 187 (60%) in the IV group expressed preference for oral therapy (p = 0.028). Limitations in family and work commitment were more frequently perceived by patients on IV than oral chemotherapy (147 (47%) vs 14 (29%) patients, p
AB - Aim: To assess patient perception toward oral chemotherapy for solid tumors, the Italian Association of Medical Oncology performed a large multi-institutional national survey. Methods: A 17-item anonymous questionnaire including 7 general and 10 investigational questions with free-text, single-choice, or multiple-choice answers was administered. Analysis of response distribution according to predefined factors was described by summary measures and conducted by χ2 test and other nonparametric tests. Results: From January to June 2010, 581 patients completed the questionnaire; data of 404 patients constituted the final study sample. Three groups could be distinguished according to treatment: IV chemotherapy (IV group, n = 313), oral chemotherapy (oral group, n = 48), or combined therapy (combined group, n = 43). Thirty-one (72%) patients in the combined group and 187 (60%) in the IV group expressed preference for oral therapy (p = 0.028). Limitations in family and work commitment were more frequently perceived by patients on IV than oral chemotherapy (147 (47%) vs 14 (29%) patients, p
KW - IV chemotherapy
KW - Oral chemotherapy
KW - Patient perspective
KW - Questionnaire
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=84962833468&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962833468&partnerID=8YFLogxK
U2 - 10.5301/tj.5000383
DO - 10.5301/tj.5000383
M3 - Article
VL - 102
SP - 108
EP - 113
JO - Tumori
JF - Tumori
SN - 0300-8916
IS - 1
ER -